Market News AIOpen the app

Mizuho lowered its price target for REGENXBIO to $18, down from $19.

OpinionRead the original at marketscreener.com
Neutral

Mizuho lowered its target but kept its Outperform rating. These opposing analyst views report no change in REGENXBIO's business, so the company outlook stays unchanged.

RGNX · REGENXBIO Inc.

AI read · Neutral

The AI's read

The lower target shows Mizuho sees less value in the shares than before. Keeping its Outperform rating shows the firm still favors them. The update reports no change in REGENXBIO's business, so it does not change the company's outlook.

Get alerts for RGNX

Follow REGENXBIO Inc. (RGNX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for RGNX
Free on the App Store and Google Play, or on the web.